Estrella Immunopharma: ), 1,000,000 Shares Of Common Stock Issued To Pipe Investors (as Defined Below) And 1,419,700 Shares Held By Uptd S Initial Stockholders, Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Unregistered Sale Of Equity Securities, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Amendments To The Registrant S Code Of Ethics, Or Waiver Of A Provision Of The Code Of Ethics, Change In Shell Company Status, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Estrella Immunopharma Inc
• Registration country
  USA
• Industry
  Financial Markets
• М/S&P/F
  *** / *** / ***